During inflammatory bowel disease, high mucosal and fecal concentrations of lipocalin-2 occur [51,52,53], but lipocalin-2 can also be used as a more general biomarker of intestinal inflammation [54]. The gene discussed is LCN2; the disease is inflammatory bowel disease.